Skip to main content
Figure 8 | Journal of Hematology & Oncology

Figure 8

From: Protein biomarkers distinguish between high- and low-risk pediatric acute lymphoblastic leukemia in a tissue specific manner

Figure 8

Kaplan-Meier survival analysis. A: Overall survival curves of patients according to APOA1, CERU, FIBB, FIBG, IGHG1, IGHG2, S10A9, SAA, TTHY, A2MG, APOA1, ACTB, CATA, CERU, FIBB, FIBG, HPT, HEMO, IGHG1, S10A9 (p<0.01); Survival rates between: B: males and females; C: low- and high-risk cases; D: TEL/AML1 positive and negative patients; E: BCR/ABL positive and negative patients; F: MLL positive and negative patients; G: MRD positive and negative patients; H: CNS positive and negative patients; I: Indicatevely, a survival curve for the ACTB protein, which did not manifest significant differences in survival rates. The same was true for all proteins under study.

Back to article page